HEPATIC IMPAIRMENT MEASURED BY QUANTITATIVE TESTS OF LIVER FUNCTION (QLFTS) PREDICTS CLINICAL OUTCOME IN PATIENTS WITH ADVANCED FIBROSIS: RESULTS FROM THE HEPATITIS C ANTIVIRAL LONG-TERM TREATMENT AGAINST CIRRHOSIS (HALT-C) TRIAL

被引：0
|
作者：
Everson, Gregory T. [1 ]
Hoefs, John C. [2 ]
Shiffman, Mitchell L. [3 ]
Morgan, Timothy R. [2 ]
Sterling, Richard K. [3 ]
Curto, Teresa M. [5 ]
Wagner, David [4 ]
Wright, Elizabeth C. [6 ]
Everhart, James E. [6 ]
机构：
[1] Univ Colorado, Transplant Ctr & Hepatol, Aurora, CO USA
[2] Univ Calif Irvine, Div Gastroenterol & Hepatol, Irvine, CA USA
[3] VCU, Sect Hepatol, Richmond, VA USA
[4] Metab Solut, Nashua, NH USA
[5] New England Res Inst, Watertown, MA 02172 USA
[6] NIDDK, Bethesda, MD USA
来源：
HEPATOLOGY | 2009年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1627
引用
收藏
页码：1057A / 1058A
页数：2
相关论文
共 50 条
  • [1] Evolution of Hepatic Steatosis in Patients with Advanced Hepatitis C: Results from the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial
    Lok, Anna S.
    Everhart, James E.
    Chung, Raymond T.
    Kim, Hae-Young
    Everson, Gregory T.
    Hoefs, John C.
    Greenson, Joel K.
    Sterling, Richard K.
    Lindsay, Karen L.
    Lee, William M.
    Di Bisceglie, Adrian M.
    Bonkovsky, Herbert L.
    Ghany, Marc G.
    Morishima, Chihiro
    HEPATOLOGY, 2009, 49 (06) : 1828 - 1837
  • [2] HEPATIC STEATOSIS DECREASES WITH ADVANCING HEPATIC FIBROSIS: FINDINGS FROM THE HEPATITIS C ANTIVIRAL LONG-TERM TREATMENT AGAINST CIRRHOSIS TRIAL (HALT-C)
    Lok, Anna S. F.
    Everhart, James E.
    Chung, Raymond T.
    Kim, Hae-Young
    Everson, Gregory T.
    Hoefs, John C.
    Greenson, Joel K. K.
    HEPATOLOGY, 2008, 48 (04) : 1101A - 1101A
  • [3] Clinical model to predict cirrhosis in patients in the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.
    Lok, AS
    Everhart, JE
    Everson, G
    Wright, EC
    Sterling, R
    Ghany, M
    Goodman, Z
    HEPATOLOGY, 2002, 36 (04) : 315A - 315A
  • [4] Design of the halt-c trial (hepatitis C antiviral long-term treatment to prevent cirrhosis).
    Di Bisceglie, AM
    Bonkovsky, HL
    Dienstag, JL
    Everson, GT
    Lindsay, KL
    Gretch, DR
    Hoefs, JC
    Lee, WH
    Lok, AS
    Tralka, TS
    Shiffman, ML
    Wright, EC
    GASTROENTEROLOGY, 2000, 118 (04) : A1435 - A1435
  • [5] Prolonged antiviral therapy with peginterferon to prevent complications of advanced liver disease associated with hepatitis C: Results of the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial
    Di Bisceglie, Adrian M.
    Shiffman, Mitchell L.
    Everson, Gregory T.
    Lindsay, Karen L.
    Everhart, James E.
    Wright, Elizabeth C.
    Lee, William M.
    Lok, Anna S.
    Bonkovsky, Herbert
    Morgan, Timothy R.
    Dienstag, Jules L.
    Ghany, Marc
    Morishima, Chihiro
    Snow, Kristin K.
    HEPATOLOGY, 2007, 46 (04) : 290A - 290A
  • [6] PREDICTING CLINICAL OUTCOME USING STANDARD LABORATORY TESTS: ANALYSIS OF THE HEPATITIS C ANTIVIRAL LONG-TERM TREATMENT AGAINST CIRRHOSIS (HALT-C) COHORT
    Ghany, Marc G.
    Lok, Anna S. F.
    Everhart, James E.
    Everson, Gregory T.
    Lee, William M.
    Curto, Teresa M.
    Wright, Elizabeth C.
    Stoddard, Anne M.
    HEPATOLOGY, 2008, 48 (04) : 1105A - 1105A
  • [7] Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: Results from the hepatitis C antiviral long-term treatment against cirrhosis trial
    Everson, Gregory T.
    Shiffman, Mitchell L.
    Hoefs, John C.
    Morgan, Timothy R.
    Sterling, Richard K.
    Wagner, David A.
    Lauriski, Shannon
    Curto, Teresa M.
    Stoddard, Anne
    Wright, Elizabeth C.
    HEPATOLOGY, 2012, 55 (04) : 1019 - 1029
  • [8] Statin Use Reduces Risk of Progression of Liver Fibrosis, Among Patients With Chronic Hepatitis C: Analysis of the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial
    Simon, Tracey G.
    King, Lindsay Y.
    Zheng, Hui
    Chung, Raymond T.
    GASTROENTEROLOGY, 2014, 146 (05) : S966 - S966
  • [9] Herbal product use by persons enrolled in the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial
    Seeff, Leonard B.
    Curto, Teresa M.
    Szabo, Gyongyi
    Everson, Gregory T.
    Bonkovsky, Herbert L.
    Dienstag, Jules L.
    Shifftnan, Mitchell L.
    Lindsay, Karen L.
    Lok, Anna S. F.
    Di Bisceglie, Adrian M.
    Lee, William M.
    Ghany, Marc G.
    HEPATOLOGY, 2008, 47 (02) : 605 - 612
  • [10] HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial
    Morishima, Chihiro
    Morgan, Timothy R.
    Everhart, James E.
    Wright, Elizabeth C.
    Shiffman, Mitchell L.
    Everson, Gregory T.
    Lindsay, Karen L.
    Lok, Anna S. F.
    Bonkovsky, Herbert L.
    Di Bisceglie, Adrian M.
    Lee, William M.
    Dienstag, Jules L.
    Ghany, Marc G.
    Gretch, David R.
    HEPATOLOGY, 2006, 44 (02) : 360 - 367
12345